Enjaymo Marks Latest Milestone In Sanofi’s Blood Disorder Effort

 
• By Alaric DeArment

The company plans to draw on experience with other rare blood disorder drug launches, but pointed to some differences in the market for cold agglutinin disease.

3-D Rendering Red Blood Cells
Sanofi won approval for Enjaymo in cold agglutinin disease • Source: Shutterstock

More from New Products

More from Scrip